Abstract
Objective: To study erectile dysfunction in diabetic patients seen in two clinics in the city of Bobo-Dioulasso, Burkina Faso. Materials and Methods: A prospective cross-sectional descriptive study was conducted at the Souro Sanou Teaching Hospital (CHUSS) and the Saint Leopold clinic in Bobo-Dioulasso, from March 1 to September 1, 2012. A total of 107 patients data were collated and analysed, which was then grouped into two: the ED group, designating patients with erectile dysfunction and the NED group consisting of those patients without. The sample comprised of 61 patients with types 1 and 2 diabetesand were aged between 25-70 years. The IIEF-5 was used to evaluate erectile dysfunction. Results: The prevalence of erectile dysfunction was 57%. The average age of patients was 54.4 ± 8.3 years. All patients with ED had type 2 diabetes. The mean disease duration of diabetes was 7.2 ± 6 years. Erectile dysfunction was severe in 32.8% of cases, moderate in 31.1% of cases and mild in 36.1%. Its severity was significantly associated with glycated hemoglobin, triglycerides and BMI. Phosphodiesterase types 5 (PDE5) inhibitors were found to be effective in the treatment of erectile dysfunction with a satisfactory therapeutic response in 77.4% of users. Conclusion: Erectile dysfunction is a common complication in diabetic patients. Its occurrence and severity are influenced by several factors. The potential presence of this disorder should be assessed due to its negative impact on quality of life. Phosphodiesterase type 5 inhibitors are an effective treatment modality in diabetic patients.
Highlights
Diabetes is a serious public health problem, which according to the International Diabetes Federation, occurs in 2% - 3% of the adult population in Burkina Faso [1]
In other studies found in the literature, the prevalence of erectile dysfunction in diabetic patients have reported ranging from 16% to 95.5% [2,3,6,7]
Erectile dysfunction is commonly found among patients with diabetes, especially among those with the type 2 designation
Summary
Diabetes is a serious public health problem, which according to the International Diabetes Federation, occurs in 2% - 3% of the adult population in Burkina Faso [1]. Microangiopathy is one of its many chronic complications, and can lead to erectile dysfunction. The prevalence of erectile dysfunction among patients with diabetes indiabetics is approximately 16% to 95.5% worldwide [2,3]. Despite the efficacy and availability of phospho-diesterase type 5 inhibitors and intracavernous injections in the treatment of erectile dysfunction in diabetic patients [4], it is still at a boo subject in frequently broached by patients. With the growing number of diabetic patients in Burkina Faso, it is becoming increasingly relevant to study this population. Diagnostic modalities and therapeutic options will contribute to a better understanding of this phenomenon and how to improve its management
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
